Sellas Life Sciences has reported the multicentre Phase IIa trial data of a highly selective cyclin-dependent kinase 9 (CDK9) ...

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

"We found that pharmacologically targeting a single kinase, CDK2, can trigger two distinct cellular responses depending on ...

MEI Pharma, Inc. (Nasdaq: MEIP) (the "Company") today reported results for its quarter ended December 31, 2024.

Tyk Medicines Inc. has patented new cyclin-dependent kinase 2 (CDK2) and/or cyclin-dependent kinase 4 (CDK4) inhibitors reported to be useful for the treatment of cancer, infections, metabolic ...

Cyclin-dependent kinases 4 and 6 (CDK4/6) are crucial cell cycle regulators and have become significant targets in breast cancer therapy. Current CDK4/6 inhibitors, while effective, often come with ...

Auto Tech Firm CDK Reaches $630 Million Settlement in US Dealer Data Case By Mike Scarcella (Reuters) -Automotive technology giant CDK Global has agreed to pay $630 million to settle antitrust ...

– Updated overall survival (OS) results – a key secondary endpoint – reinforce the significant benefit of the Itovebi TM (inavolisib)-based regimen for patients with advanced PIK3CA-mutated ...

Cyclin B3, on the other hand, plays an important role in meiosis, another type of cell division. It is responsible for ensuring that meiotic division takes place correctly and that a healthy egg ...

Jan 28 (Reuters) - Automotive technology giant CDK Global has agreed to pay $630 million to settle antitrust claims that it caused hundreds of software vendors to overpay for vehicle dealership ...

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.